NCT05803629View on ClinicalTrials.gov

Characterizing Histiocytosis With 68Ga-FAPI PET/CT

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

December 31, 2025

Conditions
Histiocytosis
Interventions
DIAGNOSTIC_TEST

68Ga-FAPI

Intravenous injection of one dosage of 74-148 MBq(2-4 mCi) 68Ga-FAPI.

DIAGNOSTIC_TEST

18F-FDG

Intravenous injection of one dosage of 7.4MBq/kg(0.2mCi/kg) 18F-FDG. 18F-FDG PET/CT is performed within one week from 68Ga-FAPI PET/CT scan.

Trial Locations (1)

Unknown

Department of Nuclear Medicine, Peking Union Medical College Hopital, Chinese Academy of Medical Science, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT05803629 - Characterizing Histiocytosis With 68Ga-FAPI PET/CT | Biotech Hunter | Biotech Hunter